|
Advertisement | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Molecular & Cellular Proteomics 8:273-286, 2009.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ABSTRACT |
|---|
|
|
|---|
Unfortunately, experiments combining cross-linking with mass spectrometry involve many technical challenges. For example, the combinatorial nature of protein cross-links creates an intrinsic problem of identification when assayed by mass alone. Additionally insufficient fragmentation of cross-linked peptides during MS/MS sequencing often results in mass spectra that are difficult to interpret. The relatively low number of cross-links compared with non-cross-linker-containing peptides produced during proteolysis of the protein complex presents another analytical challenge.
Several recent developments have resolved some of these issues. Mass spectrometers capable of determining molecular weight with high mass accuracy, such as FTICR-MS instruments, reduce the number of potential cross-links that can be assigned to a specific mass (1, 6). Also the specific mass spectrometric "signature" provided by isotopically coded cross-linkers (7) and isotope labeling of cross-links during proteolysis (8) has been a crucial development for straightforward MS detection of cross-links. We recently reported an isotopically coded, chemically cleavable cross-linker that allows discrimination between cross-link types (dead end, intrapeptide, or interpeptide) and facilitates subsequent MS/MS sequencing of the individual peptides that constitute an interpeptide cross-link (9). We have also reported a specific photocleavage of fluorescent monobromobimane (MBB)1-labeled cysteine residues that occurs under MALDI conditions (10).
Based on this observation, we designed a cross-linker called BiPS (bimane bisthiopropionic acid N-succinimidyl ester) that is structurally similar to MBB-modified cysteine and can therefore be photocleaved under MALDI conditions (see Fig. 1A). Eight deuterium atoms were incorporated into the structure of H8-BiPS (D8-BiPS) to assist in the detection of both the cross-links and the peptides obtained after photocleavage when a 1:1 mixture of H8-BiPS and D8-BiPS is used. H8-BiPS/D8-BiPS mixtures thus allow complementary detection of the cross-links by fluorescence and by MS. Laser-induced photocleavage of the cross-linker facilitates cross-link identification and cross-link type assignment by a combination of accurate mass and MS/MS sequencing of each individual peptide. These characteristics make this novel cross-linker a powerful tool for studying protein structure and protein-protein interactions. Here we report a proof-of-principle study of the interaction of G-protein-coupled receptors (GPCRs) and β-arrestins using our novel cross-linker. GPCRs, also referred to as "seven membrane-spanning receptors," constitute the largest known family of cell surface receptors. These proteins are common targets of modern drug therapy because they mediate a diverse group of intercellular signaling events (11). The dynamic sensitivity of GPCR function and signaling is due in large part to their regulation by the G-protein-coupled receptor kinase/β-arrestin system. Upon agonist activation, G-protein-coupled receptor kinase-mediated phosphorylation of the C terminus of the receptor initiates binding of the multifunctional adaptor and transducer proteins, the β-arrestins, to the receptor. This interaction leads to the desensitization of G-protein-mediated signaling, internalization of the receptor, and activation of a growing list of β-arrestin-dependent signaling cascades and cellular processes. However, little is known about the structural basis of this interaction. Although a complete elucidation of the structural basis must await resolution of the atomic structure of the receptor-β-arrestin complex, our structural proteomics methodology (combining MS with the novel BiPS cross-linker) has provided new direct structural information on the interaction between GPCR and β-arrestin.
|
| EXPERIMENTAL PROCEDURES |
|---|
|
|
|---|
8 with HCl, and 0.1 mmol of dibromobimane (Calbiochem) was added. The solution was mixed until completely dissolved and kept at room temperature for 1 h. The pH was adjusted to
8 by addition of NaOH (for H8-BiPS) or NaOD (for D8-BiPS). Bimane bisthiopropionic acid was precipitated by addition of HCl, filtered, washed with 1 mM HCl, and lyophilized. Equal amounts of H8- and D8-dicarboxylic acids were mixed, dissolved in DMSO, and activated with N-hydroxysuccinimide and dicyclohexylcarbodiimide overnight at room temperature. The reaction mixture was then filtered, and BiPS was precipitated by the addition of water, washed with water, and lyophilized. BiPS and its deuterated derivative were characterized by nano-ESI (QSTAR, Applied Biosystems, Framingham, MA) under the experimental conditions and parameter settings described elsewhere (13).
Protein Cross-linking Procedure
Cross-linker Solution—
A 1:1 mixture of H8-BiPS:D8-BiPS was used for all cross-linking reactions. Cross-linkers were stored as 10 mM stock solution in DMSO at –20 °C and were added directly to a solution of the protein in PBS to give a final concentration as described below.
Cross-linking of RNase S—
RNase S (1 mg/ml in PBS, pH 8.0) was cross-linked with 0.5 mM BiPS for 30 min at 25 °C. The reaction was quenched by adding 50 mM ammonium bicarbonate, and proteins were separated by SDS-PAGE. Protein bands containing cross-linker were visualized using a UV illuminator with a 362-nm excitation filter. The fluorescent band, corresponding to cross-linked RNase S, was excised and in-gel digested with porcine trypsin (sequencing grade, Promega) according to the protocol described previously (14, 15), separated by HPLC, and analyzed by MALDI-MS as described below.
Cross-linking of β-Arrestins and V2Rpp—
The synthesis of phosphopeptide V2Rpp and the corresponding non-phosphorylated peptide, V2Rnp, have been described previously (16). The peptide sequence is ARGRTPPSLGPQDESCTTASSSLAKDTSS (phosphorylated residues are underlined). The procedures for purification of rat β-arrestins has been reported elsewhere (17). Briefly wild-type rat β-arrestin 1 was subcloned into a pGEX4T1 vector and overexpressed in Escherichia coli strain BL21(DE3)pLysS. Clarified cell lysate was loaded onto a glutathione-Sepharose column, and β-arrestin 1 was cleaved from the affinity-bound GST-β-arrestin 1 by digestion with thrombin. The cleaved β-arrestin 1 was further purified on a 5-ml HiTrap Mono Q column followed by gel filtration on a Superdex 75 column. For the cross-linking reaction, two samples were run in parallel: one with V2Rpp and the other with V2Rnp, both in a 1:1 ligand:protein ratio. One picomole of β-arrestin 1 in PBS buffer, pH 8.0, was incubated with V2Rpp or V2Rnp and 0.25 mM cross-linker for 30 min at 25 °C. Unreacted cross-linker was quenched by incubation with 100 mM ammonium bicarbonate for
20 min after which the sample was separated by SDS-PAGE. Finally the corresponding protein band was in-gel digested overnight at 25 °C with trypsin (1:10 molar ratio of trypsin to β-arrestin) and analyzed by MALDI-MS as described below.
Rat β-arrestin 2 was overexpressed in E. coli as C-terminally His-tagged protein and was purified using nickel-nitrilotriacetic acid-Sepharose followed by gel filtration on Superdex 75. Two cross-linking reactions were run in parallel: with and without V2Rpp. One nanomole of β-arrestin 2 in PBS buffer, pH 8.0, was incubated with 0.25 mM cross-linker for 30 min at 25 °C with or without V2Rpp. Unreacted cross-linker was quenched by incubation with 100 mM ammonium bicarbonate for
20 min, digested with trypsin (1:10 molar ratio) overnight at 37 °C, separated by HPLC, and analyzed by MALDI-MS as described below.
HPLC Separation of Cross-linked Peptides—
Tryptic peptides were separated and collected (1-ml fractions) by reversed phase HPLC with fluorescence detection using a 60-min linear gradient of 5–65% acetonitrile in 0.1% TFA at 1 ml/min on an HP1100 (Agilent) LC instrument equipped with a Vydac 218TP54 (C18, 5 µm, 250 x 4.6-mm) column (The Nest Group, Inc., Southborough, MA). Lyophilized fractions were reconstituted in 10 µl of 0.1% TFA, 50% acetonitrile; mixed with matrix solution; and applied to the MALDI target plate as described previously (18).
MS Analysis of Cross-linked Peptides—
Mass spectrometric analyses were performed on a MALDI-TOF/TOF mass spectrometer (4700 Proteomics Analyzer, Applied Biosystems) operating in the reflectron mode. MALDI-MS spectra were screened for the presence of ion signal doublets/multiplets 8.05 and 4.03 Da apart. The screening and analysis of ion doublets was automated by means of a customized software program (isotopically coded cleavable cross-linking analysis software suite (ICC-CLASS)) developed in our laboratory (details to be published elsewhere).
Briefly the program consists of three modules. The first module, DXSet, searches the MS mass lists for presence of D8 and D4 peak doublets. The second module, DXDXMatch, looks for matches for the D4 and D8 peak doublets according to masses derived from equations describing the cleavage of different types of cross-links. The third module, DXMSMSMatch, performs the assignment of uncleaved and cleaved cross-links based on matching the isotopically coded cross-linker-containing and cross-linker-free fragment ion masses (from the MS/MS spectra mass lists) to the theoretically predicted fragment ion masses. The program is capable of automatic analysis of a set of multiple spots, for example, from an LC-MALDI analysis.
Doublet peak lists produced by the DXSet module can be downloaded as inclusion lists for automatic acquisition of the corresponding MSMS spectra, which in turn can be automatically analyzed by the DXMSMSMatch module. For the work described here, both doublet ions were simultaneously selected for tandem analysis by MALDI-TOF/TOF. For assignment of cross-linked peptides by mass, the MS-Bridge (Protein Prospector, Mass Spectrometry Facility, University of California San Francisco; bridge elemental composition for BiPS, C16H16N2O4S2) and ICC-CLASS programs were used to predict all possible combinations of cross-linked peptide masses. Fragment ions were manually matched to theoretical peptide fragments calculated by the MS-Product program (Protein Prospector, University of California San Francisco) and by the DXMSMSMatch module of ICC-CLASS.
Molecular Modeling of the Phosphopeptide V2Rpp-β-Arrestin Interaction Site—
We used Medusa (19–21), a general molecular modeling and design program, to determine the structure of the unbound state of the 29-mer synthetic phosphorylated peptide representing the C terminus of vasopressin type II receptor. Because the current version of Medusa contains no force field for phosphate groups, we substituted all the phosphorylated residues with glutamic acid to mimic the negatively charged phosphoryl groups. We also incorporated the distance constraints that represent known secondary structure information to force the sampled conformations to be consistent with the conserved secondary structure prediction by the PHD program (22). We performed a replica-exchange molecular dynamics simulation (23) with eight replicas at temperatures from 0.4 to 0.63 (temperature is in the unit of
/kB where
is the energy unit and kB is the Boltzmann constant) for 105 time units. These replica-exchange simulations were followed by annealing simulations of each replica for 104 time units to a temperature of 0.1. From eight annealing simulations, we chose the conformations with the lowest energies, and that were consistent with the known secondary structure information.
Next we used a well established docking program, ZDOCK (24, 25), to determine the structure of the phosphopeptide-β-arrestin complex based on the calculated structures of each component. Among the predicted structures for the complex, we chose the structure with the least violation of experimentally derived cross-linking constraints from the structures with the lowest energies as the structural template for further refinement. Finally we used Medusa to refine the predicted structure of the phosphopeptide-β-arrestin complex so that the resulting structure of the complex satisfied all experimentally derived cross-linking constraints. In this complex, the phosphopeptide binds to the concave surface of the β-arrestin N-domain.
| RESULTS AND DISCUSSION |
|---|
|
|
|---|
Characteristic Mass Spectrometric Signatures of MALDI-MS-induced Fragmentation of BiPS—
Based on previous observations, we predicted that MALDI conditions would lead to photoinduced cleavage of BiPS-cross-linked peptides in a manner analogous to MBB-modified cysteines. Fragmentation occurs at two specific sites that are adjacent to the sulfur atom (Fig. 1B). Photocleavage produces two halves of the cross-linked peptides, both of which are isotopically labeled with four deuterium atoms in the propionic acid moiety of the cross-linker. If a 1:1 mixture of H8-BiPS/D8-BiPS is used, this photocleavage generates ion signal doublets at a 1:1 ratio and 4.03 Da apart. Moreover because of the symmetrical nature of the cross-linker, the cleavage can occur with equal probability at either of the two sulfur atoms, thus producing two 4.03-Da doublets separated by a mass difference of 190.07 Da, a difference corresponding to the mass of the bimane moiety of the cross-linker.
As we demonstrated previously for the chemically cleavable, isotopically coded cross-linker D12-EGSS (9), cross-linker cleavage facilitates analysis of the cross-linked peptides. Cleavage enables the researcher to distinguish between different types of cross-links (dead end, intra-, or interpeptide). Most importantly, cross-linker cleavage permits accurate mass determination and sequence analysis of the individual peptides constituting the cross-link, thus facilitating identification of cross-linked peptides and cross-linking sites. All of these benefits are provided by the photoinducible cleavage of BiPS. Moreover because the cleavage occurs during MALDI-MS, sample loss is negligible. This is in contrast to chemical cross-linker cleavage, which is typically not performed in situ and requires an additional purification step that may lead to sample loss.
Dead-end BiPS cross-links can be assigned based on the occurrence of two 4.03-Da ion doublets that are 104 and 294 Da lower than the mass of the 8.05-Da doublet of the non-cleaved cross-links (Fig. 1C). Individual peptides derived from cleavage of BiPS interpeptide cross-links appear as doublets separated by 4.03 Da with the m/z values of the singly charged modified peptide equal to the mass of the unmodified uncharged peptide plus 89 and/or 279 Da.
According to our studies on H8-BiPS/D8-BiPS-cross-linked peptides (data not shown), photocleavage of intrapeptide cross-links results in the formation of a disulfide-containing peptide that occurs as an 8.05-Da ion doublet that is 190 Da lower in mass than the intrapeptide cross-link (Fig. 1D). The masses of individual peptides obtained by photocleavage are related to the mass of the original non-cleaved cross-link according to the equations shown in Fig. 1, B–D. These mathematical relationships provide further verification of assigned cross-link types.
Recently we developed a simple-to-use software algorithm for automatic detection and identification of H12-EGSS/D12-EGSS cross-link types (9). Based on this algorithm, we developed a software package called ICC-CLASS to carry out fully automated detection and assignment of isotopically coded cleavable dead-end, intra-, and interpeptide cross-links (Fig. 1E). The ICC-CLASS program can also generate lists of masses, including BiPS-containing uncleaved and cleaved cross-links, and these lists can be downloaded for automated MS/MS acquisition on a MALDI-TOF/TOF instrument. Moreover ICC-CLASS is capable of analyzing and interpreting MS/MS spectra by assigning fragment ions from isotopically coded cross-links from protein complexes to known sequences. When combined with GPS ExplorerTM or Mascot analysis of MS/MS data for individual peptides obtained after cross-linker cleavage, ICC-CLASS can be used to identify unknown dead-end, inter-, and intrapeptide cross-links. This program is designed as an integrated software/instrument platform allowing a completely automated and targeted analysis of isotopically coded cross-links from data acquisition by MALDI-MS and -MS/MS to the assignment and identification of the cross-links.
Model Protein Complex RNase S—
To evaluate the applicability of BiPS and ICC-CLASS to protein cross-linking studies, we cross-linked the model complex RNase S, a small protein heterodimer consisting of a 20-mer S-peptide and a 14-kDa core protein. The cross-linking was performed with a 1:1 mixture of H8-BiPS and D8-BiPS, the reaction was quenched with ammonium bicarbonate, and the components were separated by SDS-PAGE. Protein bands containing BiPS can be conveniently visualized under UV light with a standard UV light box typically used for ethidium bromide-stained DNA agarose gels (Fig. 2A).
|
Although the UV absorbance of the peptides during HPLC was practically undetectable (data not shown), the fluorescence chromatogram did reveal the target cross-linked peptides (Fig. 2B). The small volume of sample required and increased sensitivity of fluorescence detection versus UV detection are compatible with nano-LC. This can make BiPS cross-linking suitable for electrospray LC-MS approaches with on-line fluorescence detection. On-line fluorescence detection could be used to develop a sensitive and accurate quantitative and qualitative analysis in which fluorescence-dependent MS/MS acquisition could be used for selective analysis of BiPS-containing peptides. This highly sensitive and quantitative method could be useful in probing changes in protein structure, including the detection of minor conformational alterations of potential biological significance.
For off-line separation, MALDI-MS is advantageous because of the partial cleavage of BiPS under MALDI-MS conditions and the capacity for reanalysis of the same sample spots. Fig. 2C depicts the MALDI spectrum of a fluorescent fraction from an HPLC separation of cross-linked RNase S after proteolysis. Two BiPS-containing peptides and their associated photocleaved fragmentation products are indicated by two doublets 8.05 Da apart (at m/z 1256.73 and m/z 1532.88) and four doublets 4.03 Da apart, respectively. ICC-CLASS assigned the doublet at m/z 1256.73 as an interpeptide cross-link, whereas the doublet at m/z 1532.88 was assigned as a dead-end cross-link based on the specific MS signatures of the cross-link types (see above). MS/MS analysis of the peptides induced by photocleavage of the cross-linker followed by computerized assignment of the sequence-specific ions via ICC-CLASS provided unambiguous identification of the BiPS-cross-linked peptides (Fig. 2D and Table I).
|
Protein-Protein Interaction of the Vasopressin Receptor C Terminus and β-Arrestin 1—
We next applied this methodology to the elucidation of the protein-protein interaction site between vasopressin type II receptor (V2R), a member of the seven transmembrane-spanning G-protein-coupled receptor family, and its adaptor, β-arrestin. Previously we developed an in vitro receptor-β-arrestin interaction model using a 29-mer synthetic multiphosphopeptide (V2Rpp) derived from the phosphorylated C terminus of V2R. We demonstrated that V2Rpp bound to β-arrestin and simulated the effects of an activated phosphorylated GPCR, whereas the corresponding nonphosphorylated peptide, V2Rnp, had no effect (16). This in vitro model represents a simplified receptor-β-arrestin interaction system in which the binding site for the V2Rpp on β-arrestin represents that for the phosphorylated C terminus of the receptor.
To locate the binding site of V2Rpp on β-arrestin, β-arrestin 2 was cross-linked with and without V2Rpp using a 1:1 mixture of H8-BiPS and D8-BiPS. Reaction mixtures were digested with trypsin, the resulting peptides were separated by reversed-phase HPLC with on-line fluorescence detection, and the fluorescent fractions were analyzed by MALDI-MS and MALDI-MS/MS (Table II, part A). Alternatively cross-linked reaction mixtures of β-arrestin 1 with V2Rpp or V2Rnp were separated by SDS-PAGE, and the protein bands were excised and in-gel digested with trypsin. The resulting tryptic peptides were analyzed by MALDI-MS and MALDI-MS/MS (Table II, part B).
|
|
By using a methodology combining MS and our BiPS cross-linker, we successfully mapped the binding site of a receptor C terminus on the multifunctional scaffold and adaptor protein β-arrestin, thus paving the way toward elucidating the structural basis of this dynamic receptor-β-arrestin interaction. Our findings will aid in the understanding not only of the regulatory mechanism of a wide variety of GPCR-mediated physiological cellular processes but also of the molecular basis of numerous clinical diseases associated with dysregulation of GPCR signaling.
Conclusions—
In conclusion, we report here the synthesis and application of the novel cross-linker BiPS. BiPS is distinguished from other reagents by a unique combination of chemical groups that render it homobifunctional, amine-reactive, isotopically coded, fluorescent, and photocleavable under MALDI-MS conditions. These characteristics facilitate the detection and identification of cross-linked proteins and BiPS-containing peptides (cross-links).
Our study of the RNase S model protein complex demonstrated that fluorescence assists in both the detection of cross-linked proteins in a gel and fluorescent cross-links during the HPLC separation. The isotopic coding facilitates the process of MS detection of the cross-link and its constituent peptides released after cross-linker photocleavage. The benefits of the partial photoinduced cleavage of BiPS in MALDI-MS experiments are 2-fold. First, the masses and mass differences of the peptides obtained by photocleavage of BiPS are in a defined relation to each other, providing MS signatures for immediate assignment of cross-link types (dead end, intra-, or interpeptide). Second, the identification of cross-links is greatly improved because separate MS/MS analyses of the individual cross-linked peptides can be performed. A software program we developed termed ICC-CLASS uses these MS features for automated detection, assignment, and identification of BiPS cross-links.
The unique advantages of BiPS and the automation capabilities provided by ICC-CLASS facilitate the use of this cross-linking approach for structural studies in biological systems where other structural analysis methods are limited, for example in the study of receptor proteins. In this study, we describe the successful identification of the binding site of a phosphopeptide mimicking the phosphorylated C terminus of V2R to its adaptor, β-arrestin. This combination of cross-linker and software should be useful for mapping the docking sites of the intact receptor and arrestin or even more complex signaling modules, or signalosomes, either in vitro or in vivo.
| ACKNOWLEDGMENTS |
|---|
| FOOTNOTES |
|---|
Published, MCP Papers in Press, October 6, 2008, DOI 10.1074/mcp.M800265-MCP200
1 The abbreviations used are: MBB, monobromobimane; ICC-CLASS, isotopically coded cleavable cross-linking analysis software suite; GPCR, G-protein-coupled receptor; EGSS, ethylene glycol bis(sulfosuccinimidylsuccinate); V2R, vasopressin type II receptor; BiPS, bimane bisthiopropionic acid N-succinimidyl ester. ![]()
* This work was supported in part by Genome Canada, Genome British Columbia, Muscular Dystrophy Association Grant MDA3720, American Heart Association Grant 0665361U, and North Carolina Biotechnology Center Grant 2006-MRG-1107 (to N. V. D.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. ![]()
¶ Supported by an award from the American Heart Association and by a Ruth L. Kirschstein Institutional Award. ![]()
|| To whom correspondence should be addressed: Dept. of Biochemistry and Microbiology, University of Victoria-Genome British Columbia Proteomics Centre, University of Victoria, 3101-4464 Markham St., Vancouver Island Technology Park, Victoria, British Columbia V8Z7X8, Canada. Tel.: 250-483-3221; Fax: 250-483-3238; E-mail: christoph{at}proteincentre.com
| REFERENCES |
|---|
|
|
|---|
-carboxybutyl)-thiophane-3,4-dicarboxylic acid.
J. Org. Chem. 12, 167
–173[CrossRef]
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Journal of Biological Chemistry |
| Journal of Lipid Research | ASBMB Today |